Skip to main content
Amvis Holdings, Inc. logo

Amvis Holdings, Inc. - Investor Relations & Filings

Listed
Ticker · 7071 ISIN · JP3128660002 T Human health and social work activities
Open in API
Filings indexed 82 across all filing types
Latest filing 2026-05-14 Regulatory Filings
Country JP Japan
Listing T 7071 · 1 venue

Key figures FY2025

Period ended 2025-09-30 · JPY
Headline annual figures for Amvis Holdings, Inc., fiscal year 2025, reported in JPY, with the source filing for each figure.
Total Revenues JPY 49.17B per the Annual Report filed 2025-12-25
Net Income JPY 3.66B per the Annual Report filed 2025-12-25
Total Assets JPY 83.95B per the Annual Report filed 2025-12-25
Total Equity JPY 36.13B per the Annual Report filed 2025-12-25
Cash from Ops JPY 6.03B per the Annual Report filed 2025-12-25

As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.

About Amvis Holdings, Inc.

https://www.amvis.com/en/

Amvis Holdings, Inc. is a healthcare company focused on strengthening and revitalizing regional healthcare systems. Its primary business is the operation of medical facility-type hospices under the brand name 'Ishinkan'. These facilities specialize in providing nursing and care for patients with chronic and terminal illnesses who have high medical dependency. The Ishinkan model is based on an innovative concept of outsourcing physician functions and sharing resources. Additionally, the company engages in a Regional Healthcare Revitalization Project, leveraging its operational expertise to offer comprehensive management support and consulting services to other medical institutions and care providers. This includes assistance with securing operating funds and organizational development to address challenges within regional medical care.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 91% confidence The document is a Japanese confirmation letter (“確認書”) filed under Article 24-5-2 of the Financial Instruments and Exchange Act, in which the CEO attests to the accuracy of the half-year report for the period ended March 31, 2026. It contains no substantive financial statements or analysis, only an officer certification. Under the Certification Rule, such attestations are classified as Regulatory Filings (RNS), not as the interim report itself.
2026-05-14 Japanese
半期報告書－第10期(2025/10/01－2026/09/30)
Interim / Quarterly Report Classification · 94% confidence The document is titled “半期報告書” (Semiannual Report) filed under the Financial Instruments and Exchange Act, covering the 10th interim accounting period from October 1, 2025 to March 31, 2026. It contains comprehensive mid-year consolidated financial statements, segment information, management’s analysis, cash flow details, and balance sheets. It is the full interim report itself (not an announcement) and thus matches the Interim / Quarterly Report category. H1 2026
2026-05-14 Japanese
Consolidated Financial Summary under Japanese GAAP for the First Six Months of the Fiscal Year Ending September 30, 2026
Interim / Quarterly Report Classification · 100% confidence The document is a 'Consolidated Financial Summary' for the first six months of the fiscal year. It contains detailed financial statements (Balance Sheets, Statements of Income, Cash Flows), segment reporting, and management discussion of results. It is a comprehensive interim report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2026
2026-05-14 English
2026年９月期第２四半期（中間期）決算短信〔日本基準〕(連結)
Regulatory Filings
2026-05-14 Japanese
上場維持基準への適合に関するお知らせ（流通株式比率について）
Regulatory Filings Classification · 95% confidence The document is an official announcement from Amvis Holdings regarding its compliance with the Tokyo Stock Exchange's listing maintenance criteria, specifically the 'tradable share ratio'. It confirms that the company has met all listing requirements as of March 2026. This type of regulatory disclosure regarding listing status, compliance, and exchange requirements falls under the 'Regulatory Filings' (RNS) category, as it is a corporate announcement concerning regulatory compliance rather than a financial report, management change, or dividend notice.
2026-04-23 Japanese
訂正臨時報告書
Share Issue/Capital Change Classification · 95% confidence The document is a 'Rinji Hokokusho' (Extraordinary Report) filed with the Kanto Local Finance Bureau in Japan. It details the issuance of stock acquisition rights (share options) to directors and employees, including specific terms, exercise prices, and conditions. In the context of Japanese regulatory filings (EDINET), this type of disclosure regarding capital structure changes and share-based compensation falls under the 'Share Issue/Capital Change' category.
2026-03-04 Japanese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.